>
Albany Molecular Research Inc logo

AMRI - Albany Molecular Research Inc Share Price

$21.74 0.0  0.0%

Last Trade - 31/08/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £488.5m
Position in Universe th / 6852
Bullish
Bearish
Unlock AMRI Revenue
Momentum
Relative Strength (%)
1m -5.35%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
207.6 226.7 246.6 276.6 402.4 570.5 720.1 771.6 +22.4%
+292.2 -80.5 +16.1 +15.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2017, AlbanyMolecular Research, Inc. revenues increased 49% to $336.8M.Net loss decreased 33% to $20.9M. Revenues reflect APIsegment increase of 61% to $205.4M, DDS segment increase of22% to $60M, Drug Product segment increase of 10% to $55M,United States segment increase of 38% to $183.1M, Asiasegment increase from $12.1M to $39.9M, Europe segmentincrease of 38% to $91.3M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AMRI Revenue Unlock AMRI Revenue

Net Income

AMRI Net Income Unlock AMRI Revenue

Normalised EPS

AMRI Normalised EPS Unlock AMRI Revenue

PE Ratio Range

AMRI PE Ratio Range Unlock AMRI Revenue

Dividend Yield Range

AMRI Dividend Yield Range Unlock AMRI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
AMRI EPS Forecasts Unlock AMRI Revenue
Profile Summary

Albany Molecular Research, Inc. is a contract research and manufacturing company. The Company operates through Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP) and Fine Chemicals (FC) segments. The DDS segment includes activities, such as drug lead discovery, optimization, drug development and small scale commercial manufacturing. The API segment includes pilot to commercial scale manufacturing of active pharmaceutical ingredients and intermediates. The DP segment includes pre-formulation, formulation and process development through commercial scale production of complex liquid-filled and lyophilized sterile injectable products and ophthalmic formulations. The FC segment includes lab to commercial scale synthesis of reagents and diverse compounds. It supplies a range of services and technologies supporting the discovery and development of pharmaceutical products, the manufacturing of API and drug product for new and generic drugs.

Directors
Last Annual December 31st, 2016
Last Interim June 30th, 2017
Incorporated August 6, 1998
No. of Shareholders: 170
No. of Employees: 3,085
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Select Market
Shares in Issue 43,119,283
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AMRI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AMRI
Upcoming Events for AMRI
Frequently Asked Questions for Albany Molecular Research Inc
What is the Albany Molecular Research Inc share price?

As of 31/08/17, shares in Albany Molecular Research Inc are trading at $21.74, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Albany Molecular Research Inc share price performed this year?

Shares in Albany Molecular Research Inc are currently trading at $21.74 and the price has moved by 47.69% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Albany Molecular Research Inc price has moved by -2.92% over the past year.

What are the analyst and broker recommendations for Albany Molecular Research Inc?

Of the analysts with advisory recommendations for Albany Molecular Research Inc, there are there are currently 0 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Albany Molecular Research Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Albany Molecular Research Inc next release its financial results?

Albany Molecular Research Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-06-30
What is the Albany Molecular Research Inc dividend yield?

Albany Molecular Research Inc does not currently pay a dividend.

Does Albany Molecular Research Inc pay a dividend?

Albany Molecular Research Inc does not currently pay a dividend.

When does Albany Molecular Research Inc next pay dividends?

Albany Molecular Research Inc does not currently pay a dividend.

How do I buy Albany Molecular Research Inc shares?

To buy shares in Albany Molecular Research Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Albany Molecular Research Inc?

Shares in Albany Molecular Research Inc are currently trading at $21.74, giving the company a market capitalisation of £n/a.

Where are Albany Molecular Research Inc shares listed? Where are Albany Molecular Research Inc shares listed?

Here are the trading details for Albany Molecular Research Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: AMRI
What kind of share is Albany Molecular Research Inc?

We were not able to load our ranking data for Albany Molecular Research Inc

Is there a Albany Molecular Research Inc share price forecast 2021?

We were not able to load any forecast data for Albany Molecular Research Inc.

How can I tell whether the Albany Molecular Research Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Albany Molecular Research Inc. Over the past six months, the relative strength of its shares against the market has been 25.14%. At the current price of $21.74, shares in Albany Molecular Research Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Albany Molecular Research Inc PE Ratio?

We were not able to find PE ratio data for Albany Molecular Research Inc.

Who are the key directors of Albany Molecular Research Inc?

We were unable to find the directors for Albany Molecular Research Inc.

Who are the major shareholders of Albany Molecular Research Inc?

Here are the top five shareholders of Albany Molecular Research Inc based on the size of their shareholding:

Similar to AMRI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.